Breaking News

Hovione Expands Inhalation Development Capabilities

Adds MG2 FlexaLAB capsule filling machine

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hovione has expanded its inhalation drug product development services with a new high precision MG2 FlexaLAB capsule filling machine. The investment allows Hovione to offer expanded development services for all inhalation projects from API to formulation, to powder inhalers, to final unit dose, to support Phase II-Phase III trials.   The FlexaLAB is capable of filling as many as 3,000 capsules per hour and allows 100% net weight unit verification, according to the company, for increased precisio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters